In the latest twist in the ocean of Zantac-related litigation playing out across state courts, drugmakers have notched a key ...

Delaware's top court reversed a ruling that allowed expert testimony in Zantac cancer lawsuits, citing improper legal ...

Delaware's Supreme Court sides with drugmakers including GSK (GSK) and Pfizer (PFE), rejecting expert testimony linking ...

The Delaware Supreme Court rejected the legitimacy of expert testimony linking the heartburn drug Zantac to cancer, in a ...

Delaware's highest court ruled on Thursday that nearly 75,000 patients suing four large drugmakers cannot introduce reports ...

A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making ...

Zantac did not cause Brookfield woman's colon cancer, Cook County jury rules Jurors deliberated for just over four hours from Wednesday afternoon to Thursday morning. The three-week trial — a ...

The lawsuits were filed in state courts nationwide, but the agreements don’t completely resolve Pfizer’s exposure to claims linking Zantac and cancer.

Zantac is a drug that companies have pulled from the market due to concerns about its cancer risk. Learn more about the risks here.

The Zantac cancer scare didn’t just hit home for people with heartburn. On breast cancer forums, patients wondered whether they had been harmed by Zantac—and whether they should stop taking it.

Zantac and ranitidine are routinely used by millions of heartburn sufferers. So how did the drug become a cancer risk?

The pharmacy chains are pulling the heartburn medication from shelves after the Food and Drug Administration warned that it had detected low levels of a cancer-causing chemical in samples of the drug.